Mechanistic Target of Rapamycin Research in Diabetes and Metabolism

ein Foto hinzugefügt Health

2024-01-10 07:58:14 -

CD BioSciences, a US-based CRO serving the global life science research community, has announced the launch of its new services to study the Mechanistic Target of Rapamycin (mTOR) in diabetes and metabolism research. The mechanistic Target of Rapamycin is a serine/threonine protein kinase that is inhibited by rapamycin, a bacterial compound originally isolated from Easter Island soil that...

0 Kommentare 0 Geteilt 1K Ansichten 0 Bewertungen